NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia

  1. Lopez-Millan, B.
  2. Sanchéz-Martínez, D.
  3. Roca-Ho, H.
  4. Gutiérrez-Agüera, F.
  5. Molina, O.
  6. Diaz de la Guardia, R.
  7. Torres-Ruiz, R.
  8. Fuster, J.L.
  9. Ballerini, P.
  10. Suessbier, U.
  11. Nombela-Arrieta, C.
  12. Bueno, C.
  13. Menéndez, P.
Journal:
Leukemia

ISSN: 1476-5551 0887-6924

Year of publication: 2019

Volume: 33

Issue: 7

Pages: 1557-1569

Type: Article

DOI: 10.1038/S41375-018-0353-0 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals